- Patent Title: Treatment of inflammatory diseases with inhibitors of C5A activity
-
Application No.: US16534314Application Date: 2019-08-07
-
Publication No.: US11464868B2Publication Date: 2022-10-11
- Inventor: Renfeng Guo , Niels C. Riedemann
- Applicant: InflaRx GmbH
- Applicant Address: DE Jena
- Assignee: InflaRx GmbH
- Current Assignee: InflaRx GmbH
- Current Assignee Address: DE Jena
- Agency: Greenberg Traurig, LLP
- Agent Melissa Hunter-Ensor; Leslie Serunian
- Priority: EP17164573 20170403,EP17177657 20170623,EP17189938 20170907
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/18 ; A61K47/68 ; A61K31/711 ; A61P17/00 ; C07K16/28 ; C07K16/40 ; A61K39/00
Abstract:
The present invention relates to inhibitors of C5a activity and their use in the treatment of cutaneous, neutrophilic, inflammatory diseases in a subject.
Public/Granted literature
- US20200061202A1 TREATMENT OF INFLAMMATORY DISEASES WITH INHIBITORS OF C5A ACTIVITY Public/Granted day:2020-02-27
Information query
